Case Report: Fatal Multiorgan Failure and Heterochronous Pneumonitis Following Pembrolizumab Treatment in a Patient With Large-Cell Neuroendocrine Carcinoma of Lung.

Xie, Xiaohong; Wang, Fei; Qin, Yinyin; Lin, Xinqing; Xie, Zhanhong; Liu, Ming; Ouyang, Ming; Luo, Bihui; Gu, Yingying; Li, Shiyue; Gu, Dejian; Chen, Rongrong; Zhou, Chengzhi

Xie, Xiaohong; Wang, Fei; Qin, Yinyin; Lin, Xinqing; Xie, Zhanhong; Liu, Ming; Ouyang, Ming; Luo, Bihui; Gu, Yingying; Li, Shiyue; Gu, Dejian; Chen, Rongrong; Zhou, Chengzhi.

Afiliação

Xie X; State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wang F; First Clinical College, Guangzhou Medical University, Guangzhou, China.
Qin Y; State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Lin X; First Clinical College, Guangzhou Medical University, Guangzhou, China.
Xie Z; State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Liu M; First Clinical College, Guangzhou Medical University, Guangzhou, China.
Ouyang M; State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Luo B; First Clinical College, Guangzhou Medical University, Guangzhou, China.
Gu Y; State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Li S; First Clinical College, Guangzhou Medical University, Guangzhou, China.
Gu D; State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Chen R; First Clinical College, Guangzhou Medical University, Guangzhou, China.
Zhou C; State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Front Pharmacol ; 11: 569466, 2020.

Article em En | MEDLINE | ID: mdl-33584255

Palavras-chave

immune-related adverse events; myasthenia gravis; myocarditis; pembrolizumab; pneumonitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google